Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy

NCT07423650 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Pancreatoduodenectomy
Pain Management
Opioid Analgesia
Multimodal Analgesia

Interventions

DRUG: Nefopam 120mg/day infusion
DRUG: Lidocaine Infusion
DRUG: Peridural
DRUG: Multimodal IV analgesia

Sponsor

Iuliu Hatieganu University of Medicine and Pharmacy